Home > Browse Research > Life Sciences > Diagnostics

Diagnostics: market research reports

Diagnostics refers to the investigation and identification of disease states in medicine. The modern diagnostic industry generally falls into two broad categories: in vitro diagnostics (from the Latin meaning "in glass") and in vivo diagnostics (from the Latin meaning "in the living"). In vitro diagnostics involves the removal samples of tissue such as blood, saliva, biopsy samples from a living organism for examination in the laboratory setting, whereas in vivo diagnostics involves observing and testing tissue and function in a living organism—techniques such as medical imaging (x-rays, magnetic resonance, computed tomography, etc.) and monitoring like electrocardiography, electroencephalography, etc.).

The in vitro diagnostics industry is a near $50 billion sector that includes the manufacture of tests ranging from over-the-counter at-home kits, such as pregnancy tests, to highly sophisticated molecular (or nucleic acid) tests. In addition to the test elements (the reagents), the laboratory market that the IVD industry serves also includes sales of the equipment used to handle and analyze results. These systems include automated and high-throughput analyzers and readers to assist in handling the large volume of tests that typical hospitals and reference labs.
The medical imaging sector is a technology-intensive area of diagnostics that has traditionally been consolidated in the hands of a few large corporations. The sector is driven by innovation in both equipment (miniaturization, portability, integration with IT infrastructures) and in clinical and research application. Improvements in computer enhancement and in new contrast media as well as the advent of high-tech molecular imaging techniques has broadened the range of conditions that in vivo imaging can address.

Diagnostics Company Reports (1137)

In Vitro Diagnostics (3058)

Blood Banking & Tissue Typing (264)
Cardiovascular (59)
Clinical Chemistry (259)
Clinical Laboratory Automation (5)
Clinical Laboratory Instrumentation (37)
Coagulation (340)
Companion Diagnostics (26)
General In Vitro Diagnostics (625)
Hematology & Oncology (509)
Histology & Cytology (310)
More...

Medical Imaging (1548)

Computed Tomography (CT) (229)
Contrast Media (35)
Digital Radiography (25)
General Medical Imaging (57)
Interventional Radiology (22)
Mammography (109)
NMR & MRI (264)
Nuclear Medicine (186)
PACS (Picture Archiving Computer Systems) (98)
PET (Positron Emission Tomography) (32)
More...

Regulation (5)

Diagnostics market research reports and industry analysis

Blood Banking: Granular Analysis of the Global Market Supplier Shares, Forecasts for 40 Typing, Grouping, Screening Tests France, Germany, Italy, Japan, Spain, UK, US 6/17/2013 \| published by: Venture Planning Group ... will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next; five years, and assist industry executives in developing effective business, new product development ... \| read more...	$19,500.00
Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis 6/14/2013 \| published by: Venture Planning Group ... emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Current scientific views on epidemiology and etiology ... \| read more...	$4,500.00
Healthcare/Medical Simulation Market – By Product (Patient Simulator, Surgical Simulator, Imaging Simulation, Task Trainer), Technology (Haptic, Virtual Reality), End-Users (Academics, Hospitals, Military) & Services– Trends & Global Forecasts To 2017 6/14/2013 \| published by: MarketsandMarkets ... focus on patient safety and technological advancements, the healthcare/medical simulation industry has experienced significant growth over the past decade, except for the past 3 to 4 years, where the market witnessed slow growth due to ... \| read more...	$4,650.00
2013 Analysis of the US HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Officesâ€”Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures 6/14/2013 \| published by: Venture Planning Group ... diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories ... \| read more...	$2,300.00
2013 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures 6/14/2013 \| published by: Venture Planning Group ... Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for ... \| read more...	$6,900.00
Analysis of the Enteric Disease Testing Market in the US: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia 6/14/2013 \| published by: Venture Planning Group ... disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the ... \| read more...	$5,400.00
Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) – Trends & Global Forecasts to 2017 6/14/2013 \| published by: MarketsandMarkets ... automation is defined as the use of technology to streamline or substitute manual manipulation of equipment and processes. Laboratory automation offers technologies and engineering backing for state-of-the-art work flows in research, quality assurance, and diagnostics ... \| read more...	$4,650.00
Analysis of the Respiratory Disease Testing Market in Europe: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 6/14/2013 \| published by: Venture Planning Group ... including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, ... \| read more...	$8,300.00
Analysis of the Enteric Disease Testing Market in Europe: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia 6/14/2013 \| published by: Venture Planning Group ... disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in Europe ... \| read more...	$9,400.00
2013 Analysis of the European Pap Smear/HPV Market 6/14/2013 \| published by: Venture Planning Group ... as five-year test volume and sales forecasts by country and market segment. The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; profiles leading suppliers and recent ... \| read more...	$2,850.00
2013 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures 6/14/2013 \| published by: Venture Planning Group ... Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, ... \| read more...	$3,900.00
Analysis of the Respiratory Disease Testing Market in the US: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 6/14/2013 \| published by: Venture Planning Group ... market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US.Current scientific ... \| read more...	$4,600.00
2013 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures 6/14/2013 \| published by: Venture Planning Group ... AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK).For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following ... \| read more...	$3,950.00
Analysis of the Sexually-Transmitted Disease Testing Market in Europe: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis 6/14/2013 \| published by: Venture Planning Group ... tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views on ... \| read more...	$7,900.00
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) 6/13/2013 \| published by: Renub Research ... as well and slowly becoming the reality of future in the diagnostics industry By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 ... \| read more...	$1,400.00
Global Database of the Top In-Vitro Diagnostic Substance Producers - Company Names, Financial Performance, Key Executives, and Contact Details 6/10/2013 \| published by: Global Research & Data Services ... the world. The report includes details for more than 550 in-vitro diagnostic substance producers in the world which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other ... \| read more...	$782.00
2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Italy: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Japan: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,750.00
2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$3,500.00
Bioinformatics in IVD Testing 6/7/2013 \| published by: Kalorama Information ... test interpretation. This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact. Bioinformatics-based testing has made a huge contribution to cancer diagnosis ... \| read more...	$1,995.00
2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers 6/7/2013 \| published by: Venture Planning Group ... 2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, ... \| read more...	$6,500.00
2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines,, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00

< prev 1 2 3 4 5 6 7 8 9 10 next >